Variant report
Variant | esv3370204 |
---|---|
Chromosome Location | chr13:93867723-93867957 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs368654488 | chr13:93867757-93867758 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs61963715 | chr13:93867787-93867788 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs142631656 | chr13:93867788-93867789 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs61963716 | chr13:93867791-93867792 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs111670111 | chr13:93867794-93867795 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146040642 | chr13:93867795-93867796 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs3073914 | chr13:93867796-93867797 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs366378 | chr13:93867838-93867839 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs549402077 | chr13:93867842-93867843 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs2004191 | chr13:93867845-93867846 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs551443122 | chr13:93867855-93867856 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs112936720 | chr13:93867903-93867904 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs535010736 | chr13:93867925-93867926 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs111253495 | chr13:93867935-93867936 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs558319828 | chr13:93867936-93867937 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs113453405 | chr13:93867938-93867939 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs112073381 | chr13:93867941-93867942 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs113539444 | chr13:93867951-93867952 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Breast cancer | 21364760 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Developmental delay | 21147756 | CNVD |
Cancer | 20164920 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17603634 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thyroid cancer | 19087340 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:93866600-93869000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr13:93867000-93868000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
3 | chr13:93867000-93868200 | Weak transcription | H9 Cell Line | embryonic stem cell |
4 | chr13:93867000-93868200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
5 | chr13:93867000-93868200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
6 | chr13:93867200-93868200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr13:93867200-93868400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
8 | chr13:93867400-93867800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
9 | chr13:93867600-93868200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
10 | chr13:93867800-93868600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr13:93867800-93869400 | Enhancers | H1 Cell Line | embryonic stem cell |